March 7, 2025 – The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss. The approval marks the first and only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback